United Kingdom· GB-APID-37103811000001109
Acitretin 25mg capsules
A acitretin product containing acitretin, registered in United Kingdom by DE Pharmaceuticals. The same ATC class is registered in 17 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Acitretin is registered in 17 of 19 countries.
Countries holding a registration under ATC D05BB02 (acitretin), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 10 of them publish a price we can compare per daily dose
Acitretin · ATC D05BB02
17 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of acitretin costs, country by country.
Normalised to the WHO defined daily dose (35 mg), the median price runs from $2.08 in Italy to $4.37 in Switzerland — a ×2.1 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Acitretin · price per daily dose (35 mg)
USD · FX 28 Sept 2026
- CH Switzerland$4.37
- IT Italy$2.08
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Acitretin
- Manufacturer
- DE Pharmaceuticals
- Country
- United Kingdom (GB)
- ATC code
- D05BB02
- ATC class
- Acitretin
- Defined daily dose
- 35 mg, O
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
147 interactions on record for acitretin.
Graded by severity as the source publishes them — 39 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Acitretin · interactions on record
147 records
- 39 severe
- 30 moderate
- 75 info
Most severe, free to view
- EthanolB05XX04severe
- MipomersenC10AX11severe
- LomitapideC10AX12severe
- IsotretinoinD10AD04severe
3 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Acitretin in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesAcitretinAlembic Pharmaceuticals Limited
- SwitzerlandAcicutan
- BelgiumNeotigason 25 mgPI Pharma
- CanadaMINT-ACITRETINMINT PHARMACEUTICALS INC
- FinlandAcitretin OrifarmOrifarm Generics A/S
- NetherlandsAcitretine CF 25 mg, capsulesCentrafarm B.V.
- NorwayAcitretin OrifarmOrifarm Generics A/S
- SpainACITRETINA IFC 25 mg CAPSULAS DURAS EFGIndustrial Farmaceutica Cantabria S.A.
Authorised across Europe · EMA
The same active substance is authorised in 24 EEA countries. Names it is sold under:
- Austria · Keracutan
- Belgium · Neotigason
- Czechia · Neotigason
- Germany · Acicutan, Neotigason
- Denmark · Acitretin Orifarm, Neotigason
- Estonia · Neotigason
- Spain · Acitretina Ifc, Neotigason
- Finland · Acitretin Orifarm, Neotigason
- France · Soriatane
- Croatia · Neotigason
- Hungary · Neotigason
- Ireland · Neotigason
- Iceland · Neotigason
- Italy · Neotigason, Zorias
- Lithuania · Neotigason
- Luxembourg · Neotigason
- Latvia · Neotigason
- Netherlands · Acitretin Aurobindo, Acitretine Cf
- Norway · Acitretin Orifarm, Neotigason
- Poland · Acitren, Neotigason
- Portugal · Neotigason
- Sweden · Acitretin Orifarm, Neotigason
- Slovenia · Neotigason
- Slovakia · Neotigason
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/715c8e78-3790-4bf3-a26e-6d5fd57f15cf GET /v1/drugs/715c8e78-3790-4bf3-a26e-6d5fd57f15cf?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "37103811000001109",
"desc": "Acitretin 25mg capsules (DE Pharmaceuticals)",
"form": "Oral capsule",
"vpid": "41736011000001108",
"source": "dmd",
"vtm_id": "774427000",
"strength": "25 mg",
"substance": "Acitretin",
"ingredient": "Acitretin",
"supplier_code": "2268901000001109"
}See everything about acitretin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.